Join the author team of the 2018 AJHP article entitled Navigating the residency application process for lesbian, gay, bisexual, and transgender student pharmacists as they discuss key questions and topics that LGBT candidates may want to consider as they navigate the pharmacy residency application and match processes. Hear from Clay Daniels, Lindsey Kelley, Christopher Scott, and Tate Trujillo as they discuss their perspectives and strategies for identifying residency programs that will provide a supportive learning environment. This is the fourth and final episode in our 2021 ASHP Pride podcast series.
SPEAKERS
Daniel J. Cobaugh, Pharm.D. FAACT, DABAT, is the vice president of publishing at ASHP and the editor-in-chief of AJHP. His responsibilities include executive leadership for the AHFS Drug Information product suite, the ASHP Special Publishing program, and AJHP. He received his Bachelor of Science degree in Pharmacy from the University of Pittsburgh in 1987 and his Doctor of Pharmacy degree, magna cum laude, from Duquesne University in 1989. He completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center/Children's Hospital of Pittsburgh. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center. He was recognized in June 2012 by the University of Pittsburgh School of Pharmacy as a distinguished alumnus and was a 2013 recipient of the University of Pittsburgh 225th Anniversary Medallion.
Dr. Clay Daniels is an EHR Application Analysts at St. Jude Children’s Research Hospital. He received his PhD in Microbiology from the University of Alabama at Birmingham and his PharmD from the University of Tennessee College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at Children’s of Alabama and a PGY2 Medication-Use Safety Residency at St. Jude Children’s Research Hospital. His practice and research focus on improving the safety of clinical decision support.
Lindsey R. Kelley, PharmD, MS, FASHP is Director of Ambulatory, Oncology, Research, and Allergy Pharmacy Services at Michigan Medicine. In this role, she also serves as Program Director for the PGY1 Community Pharmacy Residency and adjunct faculty at the University of Michigan College of Pharmacy. Dr. Kelley earned her Doctor of Pharmacy degree from The University of Arizona in Tucson. She completed a pharmacy practice residency at Abbott Northwestern Hospital in Minneapolis, MN and received her MS from the University of Minnesota College of Pharmacy while completing a two-year health-system pharmacy administration and leadership residency at University of Minnesota Health.
Dr. Kelley has been an active member of national pharmacy associations and state affiliates. She currently serves as Director-at-Large for the American Society of Health-System Pharmacists (ASHP) Section of Pharmacy Practice Leaders (SPPL). She has also served on both the ASHP Section of Pharmacy Practice Managers Advisory Group on Manager Development and Leadership Development. She served as chair of the ASHP New Practitioner Forum Executive Committee and as a member of the ASHP Council on Pharmacy Practice. Dr. Kelley was honored with the ASHP New Practitioners Forum Distinguished Service Award in 2010 and recognized as a fellow in 2019.
Christopher M. Scott is Chief Clinical & Revenue Officer at Eskenazi Health in Indianapolis, IN. Dr. Scott received his BS and PharmD from Purdue University. He completed a PGY1 residency and PGY2 critical care residency at Indiana University Health. Dr. Scott is a Board Certified Pharmacotherapy Specialist and has been recognized as a Fellow in Critical Care Medicine and a Fellow of the American Society of Health-Systems Pharmacists.
Tate N. Trujillo, PharmD, BCPS, FCCM, FASHP. Following the completion of two years post-graduate training, Dr. Trujillo was the clinical pharmacy specialist for trauma critical care for 9 years before transitioning into his current role of director of pharmacy. Currently he is responsible for pharmacy and clinical nutrition services in two acute care hospital combining for an average census of 750 patients and clinical pharmacy coverage of over 35 clinic sites. In addition, he has accountability for the Indiana Poison Center.
